Whitley Richard J, Gnann John W
Department of Pediatrics, Microbiology and Medicine, University of Alabama at Birmingham, USA.
Lancet. 2002 Feb 9;359(9305):507-13. doi: 10.1016/S0140-6736(02)07681-X.
Significant advances have been made in our understanding of the natural history and pathogenesis of viral encephalitides. The development of PCR has greatly increased our ability to diagnose viral infections of the central nervous system, particularly for herpes and enteroviral infections. Advancing knowledge has led to the recognition that some encephalitides can be reliably prevented by vaccination (eg, Japanese encephalitis and rabies). For other pathogens such as the arboviruses, the focus has been on prevention by vector control. Finally, effective therapy has been established for a very limited number of viral infections (eg, acyclovir for herpes simplex encephalitis). Other potentially useful treatments, such as pleconaril for enteroviral meningoencephalitis are under clinical evaluation. We review current understanding of viral encephalitides with particular reference to emerging viral infections and the availability of existing treatment regimens.
我们对病毒性脑炎的自然史和发病机制的理解取得了重大进展。聚合酶链反应(PCR)的发展极大地提高了我们诊断中枢神经系统病毒感染的能力,特别是对于疱疹病毒和肠道病毒感染。知识的进步使人们认识到,一些脑炎可以通过疫苗接种可靠地预防(如日本脑炎和狂犬病)。对于其他病原体,如虫媒病毒,重点一直是通过病媒控制进行预防。最后,针对极少数病毒感染已经确立了有效的治疗方法(如阿昔洛韦用于单纯疱疹病毒性脑炎)。其他潜在有用的治疗方法,如普来可那立用于肠道病毒性脑膜脑炎,正在进行临床评估。我们回顾了目前对病毒性脑炎的理解,特别提及新兴病毒感染和现有治疗方案的可用性。